| | ||||||||||||
| Yellow Fever Vaccine and Recent Reports of Associated Severe Illness Recently some cases of a severe viscerotropic adverse event after yellow fever vaccination have been described (see References) who developed severe illness following receipt of yellow fever vaccine (17D-204 or 17DD strains). Although reported in a very small proportion of approximately 300 million worldwide yellow fever vaccine recipients, this association warrants further investigation. The Robert Koch-Institut (RKI) is enhancing preexisting surveillance for yellow fever vaccine adverse events with special laboratory support. Medical doctors/clinicians are encouraged to report cases of febrile illness potentially caused by yellow fever vaccination to the RKI by one of the following methods: | ||||||||||||
| | ||||||||||||
| |
Persons who develop a fever |
Note: Because local doctors/clinicians need to be involved in the evaluation, reports cannot be accepted directly from individual patients.
|
| ||||||||